You May Also Like / View all maxioms
It doesn't look like there will be any disruption in the near term. Iran relies on the money the oil read more
It doesn't look like there will be any disruption in the near term. Iran relies on the money the oil brings in so they wouldn't be able to cut supplies for long.
These figures come at a difficult time, with regional and local newspapers subject to the same market forces as other read more
These figures come at a difficult time, with regional and local newspapers subject to the same market forces as other consumer products and media. Despite this, a number of regional newspapers have seen some very impressive results due to investment, audience research and focusing on what their readers want.
His body just can't take it any more.
His body just can't take it any more.
None of them want to lead with price, so if you have a network that is better, it's great. Spending read more
None of them want to lead with price, so if you have a network that is better, it's great. Spending on voice calls is falling even without a price war, so they don't want to cut prices.
It is going to be an interesting budget year. It'll all work out ... but it may be that we read more
It is going to be an interesting budget year. It'll all work out ... but it may be that we just meet our needs this year and do fewer wants.
Hopefully, in a year, when we come back to Iowa City, it'll be tough to get in the door because read more
Hopefully, in a year, when we come back to Iowa City, it'll be tough to get in the door because people want to come out and hear us. The goal is to keep building, and that takes time.
[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, read more
[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, after a slow start, it grew to become a $US2.3 billion ($3 billion today) blockbuster for its owner, Pfizer, in 2003.] About 80 per cent of the prescriptions were for unapproved uses - conditions like bipolar disorder, post-traumatic stress disorder, insomnia, restless legs syndrome, hot flashes, migraines and tension headaches, ... In fact, Neurontin has become a sort of all-purpose restorative for chronic discomfort of almost any type - yet there is almost no good published evidence that it works.
We played our best game of the year tonight.
We played our best game of the year tonight.
